nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Temozolomide—malignant glioma	0.505	1	CbGbCtD
Tasosartan—Irbesartan—PTGS1—malignant glioma	0.00372	0.5	CrCbGaD
Tasosartan—Candesartan—PTGS1—malignant glioma	0.00372	0.5	CrCbGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00122	0.00251	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KNG1—malignant glioma	0.00122	0.0025	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00122	0.0025	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SPHK1—malignant glioma	0.00119	0.00244	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HEY1—malignant glioma	0.00116	0.00239	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR4—malignant glioma	0.00116	0.00239	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HIST1H3B—malignant glioma	0.00113	0.00232	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—VEGFA—malignant glioma	0.00113	0.00232	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00112	0.00229	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00111	0.00229	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.0011	0.00226	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL8—malignant glioma	0.00108	0.00222	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MMP3—malignant glioma	0.00108	0.00222	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LATS2—malignant glioma	0.00107	0.0022	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00104	0.00214	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—malignant glioma	0.00104	0.00214	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JAG2—malignant glioma	0.00103	0.00212	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00102	0.00209	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—F2—malignant glioma	0.000992	0.00204	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—F2—malignant glioma	0.00098	0.00201	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—malignant glioma	0.00097	0.00199	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCR3—malignant glioma	0.00093	0.00191	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000903	0.00185	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.000887	0.00182	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—H3F3A—malignant glioma	0.000874	0.00179	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—F2—malignant glioma	0.000868	0.00178	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCR3—malignant glioma	0.000866	0.00178	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—BDKRB2—malignant glioma	0.000851	0.00175	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NTRK2—malignant glioma	0.000842	0.00173	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—YWHAE—malignant glioma	0.000842	0.00173	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FLT1—malignant glioma	0.000838	0.00172	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DUSP6—malignant glioma	0.000835	0.00171	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000834	0.00171	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000831	0.0017	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JAG1—malignant glioma	0.000824	0.00169	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH3—malignant glioma	0.000821	0.00168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LATS1—malignant glioma	0.000811	0.00166	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FBXW7—malignant glioma	0.000807	0.00166	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BDKRB2—malignant glioma	0.000792	0.00162	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—F2—malignant glioma	0.000788	0.00162	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—KNG1—malignant glioma	0.000774	0.00159	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT2—malignant glioma	0.00076	0.00156	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CG—malignant glioma	0.000754	0.00155	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000752	0.00154	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PTPN11—malignant glioma	0.000741	0.00152	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH2—malignant glioma	0.000736	0.00151	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CD—malignant glioma	0.00073	0.0015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KNG1—malignant glioma	0.00072	0.00148	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR4—malignant glioma	0.000708	0.00145	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.00069	0.00142	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT2—malignant glioma	0.00069	0.00142	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NTRK1—malignant glioma	0.000687	0.00141	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000685	0.00141	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000667	0.00137	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CD—malignant glioma	0.000663	0.00136	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000657	0.00135	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000648	0.00133	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR4—malignant glioma	0.000642	0.00132	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP3—malignant glioma	0.000638	0.00131	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000636	0.00131	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN2B—malignant glioma	0.000633	0.0013	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTK2—malignant glioma	0.000614	0.00126	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL8—malignant glioma	0.000612	0.00126	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HES1—malignant glioma	0.000604	0.00124	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NCOR1—malignant glioma	0.0006	0.00123	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—RAF1—malignant glioma	0.000592	0.00121	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2—malignant glioma	0.000584	0.0012	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CB—malignant glioma	0.000578	0.00119	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PDGFRA—malignant glioma	0.000575	0.00118	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SPP1—malignant glioma	0.000558	0.00114	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—malignant glioma	0.000555	0.00114	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000554	0.00114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MDK—malignant glioma	0.000548	0.00112	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000546	0.00112	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—malignant glioma	0.000531	0.00109	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TERT—malignant glioma	0.000529	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCR3—malignant glioma	0.000526	0.00108	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DTX1—malignant glioma	0.000522	0.00107	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PDGFB—malignant glioma	0.000516	0.00106	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGFR1—malignant glioma	0.000513	0.00105	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HIF1A—malignant glioma	0.000506	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—F2—malignant glioma	0.0005	0.00103	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CAV1—malignant glioma	0.000489	0.001	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KDR—malignant glioma	0.000484	0.000993	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000481	0.000987	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.00048	0.000985	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCR3—malignant glioma	0.000478	0.00098	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000473	0.000971	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FN1—malignant glioma	0.000466	0.000955	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—F2—malignant glioma	0.000466	0.000955	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000463	0.00095	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BAD—malignant glioma	0.00046	0.000944	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000457	0.000938	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH1—malignant glioma	0.000456	0.000935	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CD80—malignant glioma	0.000446	0.000916	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APC—malignant glioma	0.000446	0.000914	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CG—malignant glioma	0.000446	0.000914	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000444	0.00091	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGF—malignant glioma	0.00044	0.000904	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTPN11—malignant glioma	0.000438	0.000898	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—KNG1—malignant glioma	0.000438	0.000898	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—BDKRB2—malignant glioma	0.000437	0.000896	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000432	0.000886	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BRAF—malignant glioma	0.000419	0.000859	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000415	0.000852	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SUFU—malignant glioma	0.000415	0.000852	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HEY2—malignant glioma	0.00041	0.000841	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT2—malignant glioma	0.000408	0.000837	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EGFR—malignant glioma	0.000406	0.000833	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GFAP—malignant glioma	0.0004	0.000822	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KNG1—malignant glioma	0.000397	0.000815	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000397	0.000814	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CD—malignant glioma	0.000392	0.000804	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000388	0.000797	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000388	0.000796	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SPHK1—malignant glioma	0.000387	0.000795	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—malignant glioma	0.000383	0.000787	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR4—malignant glioma	0.00038	0.000779	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HEY1—malignant glioma	0.00038	0.000779	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGF2—malignant glioma	0.000375	0.00077	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIST1H3B—malignant glioma	0.000369	0.000757	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000364	0.000746	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—malignant glioma	0.000353	0.000724	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CA—malignant glioma	0.000352	0.000723	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MMP3—malignant glioma	0.000352	0.000722	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MDM2—malignant glioma	0.000351	0.00072	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RAF1—malignant glioma	0.00035	0.000718	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ERBB2—malignant glioma	0.000346	0.00071	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CB—malignant glioma	0.000341	0.000701	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JAG2—malignant glioma	0.000337	0.000691	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—malignant glioma	0.000328	0.000673	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—malignant glioma	0.000317	0.00065	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—malignant glioma	0.000314	0.000644	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—malignant glioma	0.000314	0.000643	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—malignant glioma	0.000297	0.000609	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTEN—malignant glioma	0.000295	0.000605	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—malignant glioma	0.000288	0.000591	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—H3F3A—malignant glioma	0.000285	0.000584	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—F2—malignant glioma	0.000283	0.00058	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR3—malignant glioma	0.000282	0.000579	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—YWHAE—malignant glioma	0.000274	0.000563	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTRK2—malignant glioma	0.000274	0.000563	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FLT1—malignant glioma	0.000273	0.000561	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000272	0.000558	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DUSP6—malignant glioma	0.000272	0.000558	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000271	0.000555	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000269	0.000552	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JAG1—malignant glioma	0.000269	0.000551	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH3—malignant glioma	0.000267	0.000549	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—malignant glioma	0.000266	0.000547	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000265	0.000545	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—malignant glioma	0.000264	0.000541	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FBXW7—malignant glioma	0.000263	0.00054	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BDKRB2—malignant glioma	0.000258	0.000529	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—F2—malignant glioma	0.000257	0.000527	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT2—malignant glioma	0.000248	0.000508	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CG—malignant glioma	0.000246	0.000504	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—malignant glioma	0.000245	0.000503	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PTPN11—malignant glioma	0.000241	0.000496	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH2—malignant glioma	0.00024	0.000492	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—malignant glioma	0.00024	0.000492	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000238	0.000488	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KNG1—malignant glioma	0.000235	0.000482	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—malignant glioma	0.000227	0.000465	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT2—malignant glioma	0.000225	0.000461	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTRK1—malignant glioma	0.000224	0.000459	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CD—malignant glioma	0.000216	0.000443	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CA—malignant glioma	0.000208	0.000427	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP3—malignant glioma	0.000208	0.000427	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000207	0.000426	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN2B—malignant glioma	0.000206	0.000423	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—malignant glioma	0.000201	0.000413	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTK2—malignant glioma	0.0002	0.000411	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—malignant glioma	0.000199	0.000409	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HES1—malignant glioma	0.000197	0.000404	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NCOR1—malignant glioma	0.000196	0.000401	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RAF1—malignant glioma	0.000193	0.000396	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—malignant glioma	0.00019	0.000391	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000188	0.000386	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFRA—malignant glioma	0.000187	0.000384	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SPP1—malignant glioma	0.000182	0.000373	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—malignant glioma	0.000181	0.000371	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—malignant glioma	0.000173	0.000355	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TERT—malignant glioma	0.000172	0.000354	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—malignant glioma	0.00017	0.000349	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFB—malignant glioma	0.000168	0.000345	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGFR1—malignant glioma	0.000167	0.000343	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIF1A—malignant glioma	0.000165	0.000338	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CAV1—malignant glioma	0.000159	0.000327	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KDR—malignant glioma	0.000158	0.000323	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—COX8A—malignant glioma	0.000156	0.000321	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—F2—malignant glioma	0.000152	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FN1—malignant glioma	0.000152	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BAD—malignant glioma	0.00015	0.000308	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH1—malignant glioma	0.000148	0.000305	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD80—malignant glioma	0.000145	0.000298	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CG—malignant glioma	0.000145	0.000298	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APC—malignant glioma	0.000145	0.000298	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGF—malignant glioma	0.000144	0.000295	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTPN11—malignant glioma	0.000143	0.000293	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BRAF—malignant glioma	0.000136	0.00028	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ASMT—malignant glioma	0.000133	0.000273	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT2—malignant glioma	0.000133	0.000273	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—malignant glioma	0.000132	0.000271	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CD—malignant glioma	0.000128	0.000262	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000126	0.000259	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—malignant glioma	0.000125	0.000256	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BCAN—malignant glioma	0.000125	0.000256	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF2—malignant glioma	0.000122	0.000251	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CA—malignant glioma	0.000115	0.000236	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MDM2—malignant glioma	0.000114	0.000235	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RAF1—malignant glioma	0.000114	0.000234	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB2—malignant glioma	0.000113	0.000231	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CB—malignant glioma	0.000111	0.000228	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—malignant glioma	0.000107	0.000219	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—malignant glioma	0.000103	0.000212	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—malignant glioma	0.000102	0.00021	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—malignant glioma	0.000102	0.00021	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—IDH2—malignant glioma	0.000101	0.000207	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—malignant glioma	9.67e-05	0.000198	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—malignant glioma	9.61e-05	0.000197	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.47e-05	0.000194	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—malignant glioma	9.38e-05	0.000192	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—malignant glioma	8.68e-05	0.000178	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—IDH1—malignant glioma	8.66e-05	0.000178	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—malignant glioma	8.6e-05	0.000176	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SPHK1—malignant glioma	8.38e-05	0.000172	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.21e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—malignant glioma	7.99e-05	0.000164	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—malignant glioma	7.81e-05	0.00016	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—malignant glioma	7.38e-05	0.000151	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CA—malignant glioma	6.78e-05	0.000139	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT1—malignant glioma	6.64e-05	0.000136	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—malignant glioma	6.56e-05	0.000135	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS1—malignant glioma	6.22e-05	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BCHE—malignant glioma	5.78e-05	0.000119	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.71e-05	0.000117	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—malignant glioma	5.54e-05	0.000114	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—malignant glioma	4.6e-05	9.44e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAT—malignant glioma	4.48e-05	9.19e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NCOR1—malignant glioma	4.23e-05	8.68e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAV1—malignant glioma	3.45e-05	7.07e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.14e-05	6.44e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—malignant glioma	3.03e-05	6.22e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.76e-05	5.66e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.41e-05	4.94e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—malignant glioma	2.38e-05	4.89e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—malignant glioma	2.08e-05	4.27e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.47e-05	3.01e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—malignant glioma	1.2e-05	2.46e-05	CbGpPWpGaD
